The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Open accessAbstract
Anemia is a complication that affects a majority of individuals with advanced CKD. Although relative deficiency of erythropoietin production is the major driver of anemia in CKD, iron deficiency stands out among the mechanisms contributing to the impaired erythropoiesis in the setting of reduced kidney function. Iron deficiency plays a significant role in anemia in CKD. This may be due to a true paucity of iron stores (absolute iron deficiency) or a relative (functional) deficiency which prevents the use of available iron stores. Several risk factors contribute to absolute and functional iron deficiency in CKD, including blood losses, impaired iron absorption, and chronic inflammation. The traditional biomarkers used for the diagnosis of iron-deficiency anemia (IDA) in patients with CKD have limitations, leading to persistent challenges in the detection and monitoring of IDA in these patients. Here, we review the pathophysiology and available diagnostic tests for IDA in CKD, we discuss the literature that has informed the current practice guidelines for the treatment of IDA in CKD, and we summarize the available oral and intravenous (IV) iron formulations for the treatment of IDA in CKD. Two important issues are addressed, including the potential risks of a more liberal approach to iron supplementation as well as the potential risks and benefits of IV versus oral iron supplementation in patients with CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)60865-0 · Cited by 1,492
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787
Prevalence of Anemia in Chronic Kidney Disease in the United States
Stauffer, M. E., & Fan, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084943 · Cited by 666
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
Chen, N., Hao, C., Liu, B.-C., Lin, H., Wang, C., Xing, C., Liang, X., Jiang, G., Liu, Z., Li, X., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901713 · Cited by 621
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
Chen, N., Hao, C., Peng, X., Lin, H., Yin, A., Hao, L., Tao, Y., Liang, X., Liu, Z., Xing, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813599 · Cited by 582
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Campo, S., Fazio, M. R., Nicocia, G., & Buemi, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03530708 · Cited by 561
Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation
Wish, J. B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01490506 · Cited by 556
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J. V., Murray, H., Tomson, C. R. V., Wheeler, D. C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1810742 · Cited by 502
Locatelli, F., Bárány, P., Covic, A., De Francisco, A., Del Vecchio, L., Goldsmith, D., Hörl, W., London, G., Vanholder, R., Van Biesen, W., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft033 · Cited by 471
Gupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 444
A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996) · Kidney International · doi:10.1038/ki.1996.487 · Cited by 417
How the Target Hemoglobin of Renal Anemia Should Be?
Mimura, I., Tanaka, T., & Nangaku, M. (2015) · Nephron · doi:10.1159/000440849 · Cited by 416
Coyne, D. W., Kapoian, T., Suki, W., Singh, A. K., Moran, J. E., Dahl, N. V., & Rizkala, A. R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091034 · Cited by 391
Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
Zaritsky, J., Young, B., Wang, H.-J., Westerman, M., Olbina, G., Nemeth, E., Ganz, T., Rivera, S., Nissenson, A. R., & Salusky, I. B. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05931108 · Cited by 350
Macdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K.-U., Gaillard, C., Van Wyck, D., Roubert, B., Nolen, J. G., Roger, S. D., & on behalf of the FIND-CKD Study Investigators (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu201 · Cited by 328
Shepshelovich, D., Rozen-Zvi, B., Avni, T., Gafter, U., & Gafter-Gvili, A. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.018 · Cited by 322
Kalantar-Zadeh, K., Rodriguez, R. A., & Humphreys, M. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg493 · Cited by 313
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Mikhail, A., Brown, C., Williams, J. A., Mathrani, V., Shrivastava, R., Evans, J., Isaac, H., & Bhandari, S. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0688-1 · Cited by 299
Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients
Kalantar-Zadeh, K., Regidor, D. L., McAllister, C. J., Michael, B., & Warnock, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040423 · Cited by 285
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Spinowitz, B. S., Kausz, A. T., Baptista, J., Noble, S. D., Sothinathan, R., Bernardo, M. V., Brenner, L., & Pereira, B. J. G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101156 · Cited by 262
Cai, Z., Zhong, H., Bosch-Marce, M., Fox-Talbot, K., Wang, L., Wei, C., Trush, M. A., & Semenza, G. L. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm035 · Cited by 244
Pergola, P. E., Spinowitz, B. S., Hartman, C. S., Maroni, B. J., & Haase, V. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.07.019 · Cited by 237
Self-citationComparative risk of anaphylactic reactions associated With intravenous iron products
Wang, C., Graham, D. J., Kane, R. C., Xie, D., Wernecke, M., Levenson, M., MaCurdy, T. E., Houstoun, M., Ryan, Q., Wong, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.15572 · Cited by 219
Santiago, P. (2012) · The Scientific World Journal · doi:10.1100/2012/846824 · Cited by 210
Tessitore, N., Solero, G. P., Lippi, G., Bassi, A., Faccini, G. B., Bedogna, V., Gammaro, L., Brocco, G., Restivo, G., Bernich, P., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1416 · Cited by 210
Levin, A., Djurdjev, O., Thompson, C., Barrett, B., Ethier, J., Carlisle, E., Barre, P., Magner, P., Muirhead, N., Tobe, S., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.007 · Cited by 196
Administration of Parenteral Iron and Mortality among Hemodialysis Patients
Feldman, H. I., Joffe, M., Robinson, B., Knauss, J., Cizman, B., Guo, W., Franklin-Becker, E., & Faich, G. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128009.69594.be · Cited by 192
Role for NF-κB in the regulation of ferritin H by tumor necrosis factor-α
Kwak, E. L., Larochelle, D. A., Beaumont, C., Torti, S. V., & Torti, F. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15285 · Cited by 189
Kalantar-Zadeh, K., Kalantar-Zadeh, K., & Lee, G. H. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01390406 · Cited by 189
Bailie, G. R., Larkina, M., Goodkin, D. A., Li, Y., Pisoni, R. L., Bieber, B., Mason, N., Tong, L., Locatelli, F., Marshall, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.275 · Cited by 186
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
Kalantar-Zadeh, K., Höffken, B., Wünsch, H., Fink, H., Kleiner, M., & Luft, F. C. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90649-5 · Cited by 183
Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin
Kapoian, T., O'Mara, N. B., Singh, A. K., Moran, J., Rizkala, A. R., Geronemus, R., Kopelman, R. C., Dahl, N. V., & Coyne, D. W. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050606 · Cited by 181
Fishbane, S., Pollack, S., Feldman, H. I., & Joffe, M. M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01670408 · Cited by 181
Pisani, A., Riccio, E., Sabbatini, M., Andreucci, M., Del Rio, A., & Visciano, B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu357 · Cited by 162
Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
Rostoker, G., Griuncelli, M., Loridon, C., Couprie, R., Benmaadi, A., Bounhiol, C., Roy, M., Machado, G., Janklewicz, P., Drahi, G., et al. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.01.015 · Cited by 161
Block, G. A., Fishbane, S. N., Rodríguez, M., Smits, G., Shemesh, S., Pérgola, P. E., Wolf, M. S., & Chertow, G. M. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.10.014 · Cited by 154
Iron Administration and Clinical Outcomes in Hemodialysis Patients
Feldman, H. I., Santanna, J., Guo, W., Furst, H., Franklin, E., Joffe, M. M., Marcus, S. M., & Faich, G. A. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133734 · Cited by 143
Iron supplementation to treat anemia in patients with chronic kidney disease
Besarab, A., & Coyne, D. W. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.139 · Cited by 142
Gasché, C., Ahmad, T., Tulassay, Z., Baumgart, D. C., Bokemeyer, B., Büning, C., Howaldt, S. M., & Stallmach, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000314 · Cited by 136
Onken, J. E., Bregman, D. B., Harrington, R. A., Morris, D., Buerkert, J. E., Hamerski, D., Iftikhar, H., Mangoo‐Karim, R., Martin, E. R., Martínez, C. O. A., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft251 · Cited by 133
Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation
Gómez-Ramírez, S., Brilli, E., Tarantino, G., & Muñoz, M. (2018) · Pharmaceuticals · doi:10.3390/ph11040097 · Cited by 132
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease
Agarwal, R., Rizkala, A. R., Bastani, B., Kaskas, M. O., Leehey, D. J., & Besarab, A. (2006) · American Journal of Nephrology · doi:10.1159/000096174 · Cited by 127
Safety of intravenous iron formulations: facts and folklore.
Auerbach, M., & Macdougall, I. C. (2014) · PubMed · doi:10.2450/2014.0094-14 · Cited by 122
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
Umanath, K., Jalal, D. I., Greco, B., Umeukeje, E. M., Reisin, E., Manley, J., Zeig, S., Negoi, D., Hiremath, A. N., Blumenthal, S. S., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014080842 · Cited by 121
Self-citationEffects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Fishbane, S. N., Block, G. A., Loram, L. C., Neylan, J. F., Pérgola, P. E., Uhlig, K., & Chertow, G. M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101053 · Cited by 120
Kalra, P. A., Bhandari, S., Saxena, S., Agarwal, D., Wirtz, G., Kletzmayr, J., Thomsen, L. L., & Coyne, D. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv293 · Cited by 102
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease
Panwar, B., & Gutiérrez, O. M. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.002 · Cited by 98
Renal Anemia of Inflammation: The Name Is Self-Explanatory
Yılmaz, M. İ., Solak, Y., Covic, A. C., Goldsmith, D. J. A., & Kanbay, M. (2011) · Blood Purification · doi:10.1159/000328037 · Cited by 96
Stancu, S. H., Stanciu, A., Zugravu, A. D., Bârsan, L., Dumitru, D., Lipan, M., & Mircescu, G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.043 · Cited by 89
Hepcidin is a key mediator of anemia of inflammation in Crohn's disease
Basseri, R. J., Nemeth, E., Vassilaki, M. E., Basseri, B., Enayati, P. J., Shaye, O. A., Bourikas, L. A., Ganz, T., & Papadakis, K. A. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.10.013 · Cited by 86
Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
Charytan, D. M., Pai, A. B., Chan, C. T., Coyne, D. W., Hung, A. M., Kovesdy, C. P., & Fishbane, S. N. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090922 · Cited by 85
Self-citationMarkers of iron status in chronic kidney disease
Gawęda, A. E. (2017) · Hemodialysis International · doi:10.1111/hdi.12556 · Cited by 85
Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease
Castillo-Rodríguez, E., Fernández-Prado, R., Martín-Cleary, C., Pizarro-Sánchez, M. S., Sánchez-Niño, M. D., Sanz, A. B., Fernández‐Fernández, B., & Ortíz, A. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447649 · Cited by 82
Akizawa, T., Nangaku, M., Yamaguchi, T., Arai, M., Koretomo, R., Matsui, A., & Hirakata, H. (2019) · American Journal of Nephrology · doi:10.1159/000496929 · Cited by 78
Charytan, C., Bernardo, M. V., Koch, T. A., Butcher, A., Morris, D., & Bregman, D. B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs528 · Cited by 77
Stancu, S. H., Bârsan, L., Stanciu, A., & Mircescu, G. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04280609 · Cited by 77
A bone marrow report of absent stainable iron is not diagnostic of iron deficiency
Barron, B. A., Hoyer, J. D., & Tefferi, A. (2001) · Annals of Hematology · doi:10.1007/s002770000261 · Cited by 76
Iron toxicity: relevance for dialysis patients
Fishbane, S., Mathew, A. T., & Vaziri, N. D. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft269 · Cited by 76
Kshirsagar, A. V., Freburger, J. K., Ellis, A. R., Wang, L., Winkelmayer, W. C., & Brookhart, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078930 · Cited by 65
Improved method for assessing iron stores in the bone marrow
Phiri, K. S., Calis, J. C. J., Kachala, D., Borgstein, E. S., Waluza, J., Bates, I., Brabin, B. J., & van Hensbroek, M. B. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064451 · Cited by 62
Fishbane, S. N., Singh, A. K., Cournoyer, S. H., Jindal, K. K., Fanti, P., Guss, C., Lin, V. H., Pratt, R. D., & Gupta, A. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv277 · Cited by 62
Mafodda, A., Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., & Maisano, R. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3690-z · Cited by 61
Rogers, J. T., Andriotakis, J., Lacroix, L., Durmowicz, G. P., Kasschau, K., & Bridges, K. R. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.13.2678 · Cited by 60
Challenging the Validity of the EPO Index
Kaysen, G. A., Müller, H. G., Ding, J., & Chertow, G. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.09.013 · Cited by 59
Chiang, W., Tsai, T., Chen, Y., Lin, S., & Hsieh, B.-S. (2002) · Clinical Nephrology · doi:10.5414/cnp58363 · Cited by 54
Elli, L., Ferretti, F., Branchi, F., Tomba, C., Lombardo, V., Scricciolo, A., Doneda, L., & Roncoroni, L. (2018) · Nutrients · doi:10.3390/nu10030330 · Cited by 51
Vecchio, L. D., & Locatelli, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1493455 · Cited by 41
Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients
Tarng, D. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.6.1063 · Cited by 39
Gaillard, S., Bock, A. H., Carrera, F., Eckardt, K., Wyck, D. B. V., Bansal, S. S., Cronin, M., Meier, Y., Larroque, S., Roger, S. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157063 · Cited by 39
Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease
Bahrainwala, J. Z., & Berns, J. S. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.02.002 · Cited by 38
Jain, M. R., Joharapurkar, A. A., PATEL, V. G., Kshirsagar, S. G., Sutariya, B., Patel, M. S., Patel, H., & Patel, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.023 · Cited by 25
Ciudin, A., Simó‐Servat, O., Balibrea, J. M., Vilallonga, R., Hernández, C., Simó, R., & Mesa, J. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.10.007 · Cited by 24
Iron deficiency anemia in chronic kidney disease: Uncertainties and cautions
Agarwal, R. (2017) · Hemodialysis International · doi:10.1111/hdi.12561 · Cited by 22
Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients
Çiçek, E. A., Rota, S., Dursun, B., & Kavalci, E. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1107823 · Cited by 21
Emans, M. E., Braam, B. G., Diepenbroek, A., van der Putten, K., Cramer, M. J., Wielders, J. P. M., Swinkels, D. W., Doevendans, P. A., & Gaillard, S. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000343392 · Cited by 19
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis
Shah, H. H., Hazzan, A. D., & Fishbane, S. N. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.02.007 · Cited by 18
Oral or intravenous iron for anemia correction in chronic kidney disease?
Drüeke, T. B., & Massy, Z. A. (2015) · Kidney International · doi:10.1038/ki.2015.189 · Cited by 17
Kim, I. Y., Kim, J. H., Lee, D. W., Lee, S. B., Rhee, H., Song, S. H., Seong, E. Y., & Kwak, I. S. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1409-6 · Cited by 17
Bone Marrow Iron in CKD: Correlation With Functional Iron Deficiency
Hung, S. C., & Tarng, D. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.027 · Cited by 14
Kim, T. H., Rhee, C. M., Streja, E., Obi, Y., Brunelli, S. M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw012 · Cited by 14
Self-citation
Cited by
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Portolés, J., Martín, L., Broseta, J. J., & Cases, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.642296 · Cited by 369
Metadata
- Authors
- Batchelor, E. K., Kapitsinou, P., Pergola, P. E., Kovesdy, C. P., & Jalal, D. I.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2020-02-10
- Volume
- 31
- Issue
- 3
- Pages
- 456-468
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W3006132236
- Cited by
- 334
- References
- 94
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.